Nutritional Status and Body Composition in Childhood Inflammatory Bowel Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

72 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-07-31

Study Completion Date

2017-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Malnutrition and growth retardation are common in children with inflammatory bowel disease (IBD), especially in Crohn's Disease (CD). Malnutrition is associated with disease type, anatomical location, severity of disease and age of patient. Recently, it is reported that almost all children with CD and half with Ulcerative Colitis (UC) have reduced lean mass, however, body fat alteration are not well defined.

The aim of this prospective and observational study was to evaluate nutritional and growth status and body composition of children with IBD using anthropometric measurement and bioelectrical impedance during 1 year follow-up.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Nutritional Status in Children With IBD

NCT04457518

Inflammatory Bowel Diseases Child

COMPLETED

Nutrition, Meal Regularity and Quality of Life in Inflammatory Bowel Disease

NCT07179965

Inflammatory Bowel Disease (IBD) Inflammation Nutrition +2 more

COMPLETED NA

Nutrition and Clinical Outcomes in IBD

NCT06550310

Inflammatory Bowel Diseases Crohn Disease Ulcerative Colitis +2 more

NOT_YET_RECRUITING

Body Composition in Children With Inflammatory Bowel Disease

NCT02745457

Crohn's Disease Ulcerative Colitis

COMPLETED

Nutritional Status and Body Composition of Adult Patients With Crohn's Disease

NCT04915911

Crohn Disease

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients 6 to 18 years of age at the time of enrolment who have IBD at any stage of disease activity, on any or no treatment and age- and sex-matched healthy controls will be included. All participants will be followed for 1 year.

Written informed consent will be obtained from the parents or guardians of the participants at the time of enrolment. Prospective and retrospective data will be collected. Complete family and medical history, physical examination and laboratory findings will be recorded on standard case report form. Disease activity will be scored using the Paediatric Crohn's Disease Activity Index for children with CD and the Pediatric Ulcerative Colitis Activity index for those with UC. Endoscopic data will be reviewed and disease location will be classified according to Paris classification. Puberty will be assessed based on the development of secondary sexual characteristics. At the time of enrollment and after 1 year, anthropometric measurements including height, weight, triceps skin fold thickness, middle arm circumference and assessment of body composition by bioelectrical impedance will be performed for each child. Anthropometric data will be standardized by generation of z-scores for height and weight based on age and gender. Growth deficiency for height and weight measurements will be defined as a z-score\\-2.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Bowel Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Inflammatory Bowel Disease

Patients 6-18 of age at the time of enrolment who have IBD at any stage of disease activity, on any or no treatment

Assesment of nutritional status and body composition

Intervention Type OTHER

At the time of enrollment and after 1 year, anthropometric measurements and assessment of body composition by bioelectrical impedance will be performed for each child

Control

Age- and sex-matched healthy controls

Assesment of nutritional status and body composition

Intervention Type OTHER

At the time of enrollment and after 1 year, anthropometric measurements and assessment of body composition by bioelectrical impedance will be performed for each child

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Assesment of nutritional status and body composition

At the time of enrollment and after 1 year, anthropometric measurements and assessment of body composition by bioelectrical impedance will be performed for each child

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A male or female of 6 to 18 years of age at the time of enrolment
* For children with IBD; the diagnosis of IBD are based on the combination of clinical features and serological, endoscopic, colonoscopic, and histological findings
* For controls : no evidence of inflammatory or chronic disease

Exclusion Criteria

* A male or female \< 6 years or \> 18 years old at the enrollment

* For children with IBD : Presence of other chronic diseases
* For healthy control: Any coexisting chronic disease known to affect growth, nutritional status, dietary intake, or development

Minimum Eligible Age

6 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes